bm_kashvi jain_sec b
TRANSCRIPT
About the company
Founded in 1888, by a young Chicago based physician, Dr. Wallace Calvin Abbott,the organization has been devoted to discovering new medicines,new technologies and new ways to manage health
Abbott India Limited is one of India's fastest growing pharmaceutical companies and part of Abbott's Global Pharmaceutical business in India
Executive Summary
Results 20142014 Key insights
In Rs Cr. 2014 2015
Sales Target 100 123
Market Share 17% 19%
Successful re-launch of brand Digene in 2014
▪ Brand achieves growth after stagnation of 4 years
▪ Brand franchise successfully extended through entry into high growth category of Powders
▪ Category of Antacids poised to reach Rs.2000 Crores by 2020
▪ Low penetration of the category poses high potential for growth
▪ Prescriptions for Antacids are declining as they lose preference to PPIs
▪ Growths of Gels and Tablets are flattening
Brand Plan devised based on research
variousresearches
variouscities
variousrespondents
depth interviews
HCPs +
Chemists
Fizz launch
Digene Fizz Launch (activities till date)
Sales▪On course to achieve huge monthly sachet sales by Dec’15
Media▪High frequency announcer film▪Aired across all major GEC, News and Movie Channels▪Extensive reach
BTL▪Extensive Visibility across the country
– numerous posters & dangler dispenser
▪Sampling – sachets sampled to retailers and
wholesalers
Digene is the number 2 player in overall antacids
Category evolution continues towards Powders
Reach in chemists similar across segments.
65% of powder sales occur outside of chemistsGel & Tabs growths are stagnating
Powders has evolved to be the biggest segment
Market Share
▪ Eno continues to dominate the Powders’ category with >92% market share
▪ Digene Fizz is at ever highest share (higher than Fastmelt)
▪ Digene Gels – Overtaken Gelusil in Q3’14
Tablets Market Share Gels Market Share
Digene Powder Market Share
Brand Re-launched with multiple improvements
Superior Taste Profile
▪ Existing flavours’ taste profile enhanced with cooling
New Communication
▪ New Thematic commercial ▪ Tactical announcer film for Fizz
Rural Outreach
▪ Increased distribution to smaller towns
Revamped Packaging
▪ Consumer-friendly, less-medicinal look
▪ Replaced glass bottle with PET
Sales team expansion
▪ Expansion of sales force to cater to the OTC market
Product
Consumerization of Brand
Reposition the brand to create emotional connect and strengthen functional connect with the consumers
Existing flavours’ taste profile enhanced with cooling
Segmentation and Targeting
India’s population 1360m1360m 1400m1400m
Rs. 2,000CrRs. 2,000Cr
2015 2020
Population suffering from acidity 870m870m
Population taking remedy 830m830m
Total modern remedy users 329m329m
1015m1015m
960m960m
453m453m
Assumptions
Decadal population growth rate of 17.6%
Increase in urbanization from 33.5% in 2015 to 36% in 2020
Increased accessibility & acceptability to drive growth by ~5%
Total Estimated Market
Segmentation and Targeting
Consumer driven Medicinal
“Serious” suffering“Casual” suffering
Target all sufferers of acidity and not only current users of modern remedies